BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UCB//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260418T114500
DTEND;TZID=America/Chicago:20260418T124500
SUMMARY:Industry Therapeutic Update from UCB: Scientific Exchange on New Clinical and Real-World Evidence for Fintepla (fenfluramine) in Dravet and Lennox-Gastaut Syndromes
DESCRIPTION:You are invited to join UCB for a lunchtime Industry Therapeutic Update where we will feature a scientific exchange on new clinical and real-world evidence related to fenfluramine in Dravet and Lennox-Gastaut syndromes. The program will also highlight real-world use of an updated refractory epilepsy screening tool to support identification of Lennox-Gastaut syndrome and conclude with an interactive Q&A. This program is not accredited for continuing education. Attendance is limited to healthcare professionals.
LOCATION:McCormick Place\, West Building\, Room 471\, Chicago\, IL
BEGIN:VALARM
TRIGGER:-PT30M
ACTION:DISPLAY
DESCRIPTION:Reminder: UCB Industry Therapeutic Update starts in 30 minutes
END:VALARM
END:VEVENT
END:VCALENDAR